Sibin K Zacharias 1, Robert D Safian 1, Ryan D Madder 2, Ivan D Hanson 1, Mark C Pica 1, James L Smith 1, James A Goldstein 1 and Amr E Abbas 1
|
|
- Ralf Maxwell
- 6 years ago
- Views:
Transcription
1 631420VMJ / X Vascular MedicineZacharias et al. research-article2016 Original Article Invasive evaluation of plaque morphology of symptomatic superficial femoral artery stenoses using combined near-infrared spectroscopy and intravascular ultrasound Vascular Medicine 2016, Vol. 21(4) The Author(s) 2016 Reprints and permissions: sagepub.co.uk/journalspermissions.nav DOI: / X vmj.sagepub.com Sibin K Zacharias 1, Robert D Safian 1, Ryan D Madder 2, Ivan D Hanson 1, Mark C Pica 1, James L Smith 1, James A Goldstein 1 and Amr E Abbas 1 Abstract The purpose of this study is to characterize the plaque morphology of severe stenoses in the superficial femoral artery (SFA) employing combined near-infrared spectroscopy and intravascular ultrasound (NIRS-IVUS). Atherosclerosis is the most common cause of symptomatic peripheral arterial disease. Plaque composition of SFA stenoses has been characterized as primarily fibrous or fibrocalcific by non-invasive and autopsy studies. NIRS has been validated to detect lipid-core plaque (LCP) in the coronary circulation. We imaged severe SFA stenoses with NIRS-IVUS prior to revascularization in 31 patients (46 stenoses) with Rutherford claudication class 3. Angiographic parameters included lesion location and stenosis severity. IVUS parameters included plaque burden and presence of calcium. NIRS images were analyzed for LCP and maximum lipid-core burden index in a 4-mm length of artery (maxlcbi 4mm ). By angiography, 38 (82.6%) lesions were calcified and 9 (19.6%) were chronic total occlusions. Baseline stenosis severity and lesion length were 86.0 ± 11.0% and 36.5 ± 46.5 mm, respectively. NIRS-IVUS identified calcium in 45 (97.8%) lesions and LCP in 17 (37.0%) lesions. MaxLCBI 4mm was 433 ± 244. All lesions with LCP also contained calcium; there were no noncalcified lesions with LCP. In conclusion, this is the first study of combined NIRS-IVUS in patients with PAD. NIRS-IVUS demonstrates that nearly all patients with symptomatic severe SFA disease have fibrocalcific plaque, and one-third of such lesions contain LCP. These findings contrast with those in patients with acute coronary syndromes, and may have implications regarding the pathophysiology of atherosclerosis in different vascular beds. Keywords arterial occlusive diseases, claudication, superficial femoral artery, intermittent claudication, lower extremity, peripheral arterial disease, stenosis, stents, intravascular ultrasonography, near-infrared spectroscopy Introduction Peripheral arterial disease (PAD) afflicts 8 12 million patients in the United States, 1 with the greatest prevalence in patients with age > 65 years, diabetes, chronic kidney disease, and history of smoking. PAD commonly co-exists with atherosclerotic coronary artery disease (CAD) and cerebrovascular disease (CVD), and it is presumed that atherosclerosis in different vascular territories reflects common underlying pathophysiological mechanisms. 2 The availability of invasive vascular imaging techniques has led to advances in our understanding of the pathogenesis of CAD. Recent studies of near-infrared spectroscopy (NIRS) suggest that plaque composition has important implications for plaque progression, plaque rupture and thrombosis, and risks during percutaneous coronary intervention. 3 5 Combined NIRS and intravascular ultrasound (IVUS) is a new multi-modality invasive imaging technique that provides co-registered data on plaque architecture by IVUS and lipid composition by NIRS. 6 The present study was designed to characterize plaque morphology employing NIRS-IVUS in patients with symptomatic severe superficial femoral artery (SFA) stenoses prior to percutaneous revascularization. 1 Department of Cardiovascular Medicine, Beaumont Health, Royal Oak, MI, USA 2 Frederick Meijer Heart & Vascular Institute, Spectrum Health, Grand Rapids, MI, USA Corresponding author: Amr E Abbas, Department of Cardiovascular Medicine, Beaumont Health System, 3601 W. 13 Mile Road, Royal Oak, MI 48073, USA. amr.abbas@beaumont.org
2 338 Vascular Medicine 21(4) Figure 1. Near-infrared spectroscopy (NIRS) scan from a coronary artery from an autopsy study with histologic correlation. Upper panel: Chemogram depicting a false color map of the artery wall indicating the probability of LCP along the length (x-axis, in mm) and circumference (y-axis, in degrees) of the scanned artery (red = low probability, yellow = high probability). Middle panel: Block chemogram summarizing the presence of LCP at 2-mm intervals in four probability categories (yellow, tan, orange, red). Lower panel: Russell-Movat s pentachrome-stained cross-sections (5-μm thick) at 42, 28, 24, and 6 mm, respectively, along the scanned artery (white rectangles). Image interpretation: In the chemogram, a prominent LCP signal is detected from 35 to 45 mm, occupying approximately 160 circumference. The block chemogram shows the highest probability LCP signals extend from 35 to 43 mm. The NIRS signals at 28, 24, and 6 mm demonstrate diffuse plaque with low probability of LCP. NIRS signals are confirmed by histology. (NIRS, near-infrared spectroscopy; LCP, lipid-core plaque.) Image courtesy of InfraRedX, Inc. Methods Between December 2012 and April 2015, 31 patients with Rutherford claudication class 3 underwent invasive angiography and NIRS-IVUS imaging prior to percutaneous revascularization, according to a protocol approved by the Human Investigations Committee at Beaumont Health System. Clinical, angiographic, NIRS, and IVUS analyses were performed on all target lesions. Clinical information included age, gender, Rutherford class, and co-morbidities. Angiographic technique Peripheral angiography was performed according to standard methods employing digital subtraction angiography (DSA) and 6-French vascular sheaths. A radiopaque ruler was placed adjacent to the thigh to guide NIRS-IVUS localization. Quantitative angiography (QA) was performed with Medis QAngio XA software (Rotterdam, The Netherlands) to assess lesion length, reference vessel diameter (RVD), minimum lumen diameter (MLD), and diameter stenosis (DS). Angiography was analyzed qualitatively to identify the number of calcified lesions. NIRS-IVUS (near-infrared spectroscopyintravascular ultrasound) technique NIRS and IVUS were performed over a inch guidewire using the single-catheter InfraRedX TVC Imaging System (Burlington, MA, USA). Five lesions required pre-dilation with a 2.0-mm balloon to facilitate passage of the NIRS-IVUS catheter. The system consists of a 3.2-French rapid-exchange catheter that acquires 1000 NIRS measurements/12.5 mm of artery scanned. Each measurement interrogates 1 2 mm 2 of the lumen surface area perpendicular to the long axis of the catheter, and rotational pullback is performed at 0.5 mm/s and 960 RPM. The measurement of the probability of lipid-core plaque (LCP) is displayed as a map, with the x-axis indicating the pullback position in millimeters and the y-axis the circumferential position of measurement in degrees. The map of probability of LCP is displayed in a chemogram using a false color scale. Yellow indicates a high probability of LCP, while red indicates a low probability. A summary of the presence of LCP at 2-mm intervals in four probability categories is presented as a block chemogram in (Figure 1). 3 IVUS images were acquired via a rotating transducer operating at 40 MHz. Automatic pullback was initiated 1 cm distal to the lesion, and terminated 1 cm proximal to the target lesion. Registration of NIRS-IVUS and angiographic data was obtained by the following process (Figure 2). First, the proximal and distal edges of the target lesion were identified by angiography. Second, the distance from the MLD to the proximal and distal lesion edges was measured. Third, the MLD was identified on the co-registered NIRS- IVUS image. Fourth, the lesion on the NIRS-IVUS image was defined using the measurements obtained by QA from the MLD-proximal lesion edge and MLD-distal lesion edge. Once the lesion was defined by NIRS-IVUS, a frameby-frame analysis of the entire lesion length was performed to identify the presence of calcium and LCP. The calcium
3 Zacharias et al. 339 Figure 2. Methodology used to identify SFA lesions on angiography and NIRS-IVUS. Left panel: The MLD (1) was identified by angiography. The distance from the MLD to the edges of the proximal and distal lesions was calculated (2). Middle panel: The MLD was then identified on the co-registered NIRS-IVUS image longitudinal view (3). Right panel: The NIRS-IVUS lesion was defined by the distance from the MLD to the proximal and distal edges based on measurements from angiography (4). (SFA, superficial femoral artery; NIRS-IVUS, near-infrared spectroscopy intravascular ultrasound; MLD, minimum luminal diameter.) and lipid-core burden at the MLD was highlighted in the final analysis. IVUS analysis IVUS images were analyzed as previously described. 7 The lesion length, RVD, reference vessel area, MLD, and minimum lumen area (MLA) were measured by IVUS. The plaque burden and eccentricity index (EI) were calculated as previously described. 8 The extent of calcification was assessed by measuring the circumferential arc of calcium in degrees (0 360 ) using manual calipers, the number of quadrants that the calcium occupied (0 4) at the MLD, the length of calcium in the lesion, and the percentage of lesion length that was calcified. Quadrants of calcium were defined in relation to the circumference of a circle within a given cross-section of plaque, as follows: one quadrant (< 91 ); two quadrants ( ); three quadrants ( ); and four quadrants (> 270 ). NIRS analysis Assessment of LCP was performed as previously reported for CAD by identifying at least one bright yellow block (high probability) on the NIRS block chemogram. 3 5 The amount of LCP was quantitated by the lipid-core burden index (LCBI), the maximum LCBI in any 4-mm region (maxlcbi 4mm ), the circumferential arc of LCP (0 360 ), the number of quadrants occupied by LCP (0 4), the length of LCP, and the percentage of lesion length that contained LCP. Since the combination of IVUS and NIRS permits assessment of fibrotic plaque, calcification, and LCP, we classified lesions into four groups according to the presence or absence of lipid and/or calcium. Statistical analysis Mean and standard deviation (mean ± SD) were calculated for continuous variables, and frequency (%) was calculated for dichotomous variables. SAS for Windows (version 9.3; Cary, NC, USA) was used for statistical analysis. Results Baseline characteristics were notable for advanced age, and a high incidence of diabetes, smoking, chronic kidney disease, and concomitant CAD (Table 1). Target lesions were evenly distributed between the left and right SFA; 89.1% were located above the adductor canal (Table 2). Procedural success was achieved in all lesions, including balloon angioplasty and stenting in 44 lesions and atherectomy in 4 lesions. NIRS-IVUS IVUS identified calcified plaque in 45 (97.8%) lesions in 30 (96.8%) patients; only 1 (2.2%) lesion did not contain calcium (Table 3). The circumferential distribution of
4 340 Vascular Medicine 21(4) Table 1. Baseline clinical characteristics of 31 patients with symptomatic superficial femoral artery disease. Age, years 69.5 ± 10.2 Clinical characteristics, n (%) Male 24 (77.4) Diabetes 16 (51.6) Hypertension 30 (96.8) Dyslipidemia 29 (93.5) Smoking 30 (96.8) Chronic kidney disease 8 (25.8) Coronary artery disease 24 (77.4) Table 2. Angiographic characteristics of 46 superficial femoral artery stenoses. Lesion location, n (%) Right SFA 21 (45.7) Left SFA 25 (54.3) Above adductor canal 41 (89.1) Quantitative angiography (mean ± SD) Lesion length, mm 36.5 ± 46.5 % Stenosis (visual) 86.0 ± 11.0 % Stenosis (QA) 72.9 ± 21.2 Reference vessel diameter, mm 4.8 ± 0.9 Lesion morphology, n (%) CTO 9 (19.6) Calcified 38 (82.6) SFA, superficial femoral artery; QA, quantitative angiography; CTO, chronic total occlusion. calcium was one quadrant in 30.4%, two quadrants in 28.2%, three quadrants in 26.0%, and four quadrants in 13.0% of lesions (Figure 3). The circumferential arc of calcium at the MLD was 127 ± 84, and the longitudinal extent of calcification was 77.6 ± 29.3% of lesion length. By NIRS, 17 (37.0%) lesions contained LCP, and in such lesions the maxlcbi 4mm was 433 ± 244 (Table 3). LCP was identified at the MLD of 14 (82.3%) lesions. The circumferential distribution of LCP was one quadrant in 41.2%, two quadrants in 29.4%, and three quadrants in 29.4% (Figure 3). There were no lesions with four quadrants of LCP. Lesions were classified into four types depending on the presence of calcium and/or LCP (Figure 4). The most common plaque composition was fibrocalcific plaque without LCP in 28 (60.1%) lesions. In contrast, fibrocalcific plaque with LCP was identified in 17 (37.0%) lesions, and fibrous plaque without calcium or LCP was identified in 1 (2.2%) lesion. All lesions with LCP also contained calcium; there were no non-calcified lesions with LCP. Discussion Combined NIRS-IVUS has been previously utilized to examine plaque composition in the coronary circulation in patients with acute and chronic coronary syndromes. 5,9 To our knowledge, this is the first study employing combined NIRS-IVUS for atherosclerotic plaque characterization in the peripheral circulation. Observations from the present Table 3. NIRS-IVUS (near-infrared spectroscopy-intravascular ultrasound) characteristics of 46 superficial femoral artery stenoses. IVUS Data Lesion morphology, n (%) Eccentric plaque 31 (67.4) Calcification 45 (97.8) Calcium distribution None 1 (2.2) 1 quadrant: < (30.4) 2 quadrants: (28.2) 3 quadrants: (26.0) 4 quadrants: > (13.0) Quantitative assessment, mean ± SD Reference vessel diameter, mm 6.5 ± 0.8 Minimum lumen diameter, mm 2.2 ± 0.6 Minimum lumen area, mm ± 2.8 Plaque burden, % 84 ± 7.3 Length of calcium, mm 28 ± 30 Extent of lesion calcified, % 79 ± 27 Eccentricity index 0.7 ± 0.2 NIRS Data Scan length, mm 89 ± 28 LCP in lesion, n (%) 17 (37.0) maxlcbi 4mm 433 ± 244 LCP distribution None 29 (63%) 1 quadrant: < 91 7 (15%) 2 quadrants: (11%) 3 quadrants: (11%) 4 quadrants: > (0.0) Length of lipid, mm 6.8 ± 4.4 LCP, lipid-core plaque; maxlcbi 4mm, maximum lipid-core burden index, any 4-mm segment. Figure 3. Distribution of calcified and lipid-core plaque burden in 46 superficial femoral artery lesions. study demonstrate that nearly all patients with symptomatic severe SFA disease have fibrocalcific plaque, and approximately one-third of such lesions contain LCP. Atherosclerosis is the most common cause of CAD, CVD, and PAD. Autopsy and surgical studies typically describe atherosclerosis with varying degrees of fibrous, fibrocalcific, and lipid-laden plaque. When characterized in this fashion, atherosclerosis is qualitatively similar in many
5 Zacharias et al. 341 Figure 4. Co-registered angiographic and NIRS-IVUS images. Top (1): Fibrous plaque without LCP. (a) Angiogram shows a severe focal stenosis. (b) IVUS long axis shows irregular stenosis without calcification. (c) NIRS chemogram and block chemogram show absence of LCP in target lesion. (d) Co-registered NIRS-IVUS short axis shows dense fibrous plaque at the MLD. Middle (2): Fibrocalcific plaque with LCP. (a) Angiogram shows a severe focal stenosis. (b) IVUS long axis shows irregular stenosis with calcification. (c) NIRS chemogram and block chemogram show LCP in target lesion. (d) Co-registered NIRS-IVUS short axis shows dense fibrocalcific plaque with LCP at the MLD. Bottom (3): Fibrocalcific plaque without LCP. (a) Angiogram shows a severe focal stenosis. (b) IVUS long axis shows irregular stenosis with calcification. (c) NIRS chemogram and block chemogram show absence of LCP in target lesion. (d) Co-registered NIRS-IVUS short axis shows dense fibrocalcific plaque without LCP at the MLD. (NIRS-IVUS, near-infrared spectroscopy intravascular ultrasound; LCP, lipid-core plaque; MLD, minimum luminal diameter.)
6 342 Vascular Medicine 21(4) vascular beds. However, as we develop a more sophisticated understanding of atherosclerosis, it is apparent that some arterial beds are relatively resistant to atherosclerosis (e.g. the left internal mammary artery); atherosclerotic risk factors may have different impact in different arterial beds; and phenotypic expressions of atherosclerotic plaque may vary in different arteries. 10 In fact, comprehensive morphological classifications of atherosclerotic lesions are still under debate and modification. 2,11 While contrast angiography has allowed us to describe arterial luminology, the availability of newer invasive imaging techniques has expanded our ability to characterize in vivo atherosclerosis. SFA atherosclerosis Recent autopsy and magnetic resonance imaging (MRI) studies report a high prevalence of fibrous plaque in the SFA. 8,12 According to the most recent AHA classification of atherosclerosis, 52% of SFA lesions at autopsy are classified as Type VIII (fibrocalcific plaque without LCP, in which < 50% of plaque area is calcified). 2,10 Invasive imaging for PAD Currently available intravascular imaging techniques include IVUS, optical coherence tomography (OCT), and NIRS. IVUS may be subdivided into greyscale-ivus and virtual histology-ivus (VH-IVUS). These intravascular modalities have been validated in the coronary circulation, and facilitate percutaneous coronary intervention (PCI) planning and stent implantation. Intracoronary imaging can define lumen dimensions of the target vessel, assess lesions of intermediate severity, and assess the risk for peri-procedural myocardial infarction and angiographic no-reflow. In comparison to greyscale-ivus, NIRS-IVUS provides identical IVUS information, plus information about LCP. While VH-IVUS provides a color-coded map of the atherosclerotic plaque components, including fibrous (dark green), fatty (yellow/light-green), white (calcified), and red (necrotic LCP) components, the accuracy of VH-IVUS is limited in the presence of heavy calcification. 13,14 A positive relationship has been shown between VH-derived % necrotic core plaque and NIRS-derived LCBI in non-calcified plaques, but not in calcified plaques. 15 OCT is much less practical for imaging long segments of SFA disease because of limited penetration depth and the need for large volumes of contrast. As is true for coronary angiography and CAD, peripheral angiography underestimates the extent of atherosclerosis in patients with PAD. 16 In general, IVUS applications for PAD are similar to those for CAD, including accurate assessment of lumen and vessel dimensions, enhanced assessment of lesion eccentricity and calcification, and clinical utility for ambiguous lesions before and after intervention. 17 The difference in resolution and penetration depth of ultrasound waves emitted at 40 MHz and 20 MHz frequencies (present in different commercial IVUS transducers) is negligible and did not have a significant effect on image acquisition in the SFA. 18 In a comparative analysis of angiography and IVUS in SFA disease, both provided similar information on diameter stenosis; however, RVD was larger by IVUS, and the presence and severity of calcification was better assessed with IVUS. 19 By VH-IVUS, 63% of SFA stenoses had primarily fibrous plaque, 14% had necrotic plaque, 9% had calcific plaque, and 14% had mixed plaque. Another IVUS study in the ileofemoral arteries reported that 42% of patients had plaque rupture, which was strongly associated with recent acute coronary syndromes. 20 Compared to PAD patients with popliteal disease, VH-IVUS showed that patients with tibial disease had less fibrous and fibrofatty plaque, more calcified plaque, and similar LCP. 21 The present study is the first to use NIRS-IVUS to characterize the composition of atherosclerotic plaque in patients with symptomatic PAD. Although the observed prevalence of fibrocalcific plaque (97.8%) is much higher than prior autopsy and MRI studies, the differences are probably due to the presence of severe PAD in all of our patients. Another unique observation was that 37.0% of SFA lesions contained LCP, and LCP was localized to the arc of calcified plaque. These NIRS observations in the SFA contrast sharply with those in the coronary circulation for several reasons. First, LCP by NIRS is an invasive marker for acute coronary syndromes, plaque rupture, and thrombosis 5,9 ; in the SFA, the role of LCP remains unclear. Second, while large LCP identifies patients at higher risk for embolization and no-reflow after PCI, 4 LCP was not associated with any complications after endovascular intervention in the SFA. Third, the presence of echo-attenuated plaque is considered a reliable IVUS signature for unstable CAD 22 ; while such findings are unreliable in heavily calcified lesions, identification of LCP by NIRS is not impaired by heavy calcification. Clinical implications It is well known that the burden of atherosclerosis in multiple vascular beds is correlated with cardiovascular death; SFA atherosclerosis indicates a generalized susceptibility to atherosclerosis, CAD, and cardiac death. 12 It is also known that IVUS is superior to angiography for the assessment of plaque burden in patients with CAD and PAD, but the differential impact of IVUS versus angiographic plaque burden on long-term prognosis has not been determined. Finally, while the extent of LCP seems to have a clear relationship among patients with unstable acute coronary syndromes, 23 22% of patients with mild SFA disease have LCP 24 ; further study is needed to determine if LCP burden has prognostic importance in PAD patients. It is unknown whether LCP prevalence in CAD versus PAD is due to alternative pathways for atherosclerotic plaque initiation and progression, structural differences in the arterial wall, or differential mechanical and shear forces. 10,25 Applications of NIRS-IVUS in PAD Although it is clear from previous studies in the coronary circulation that different clinical syndromes have different NIRS signatures, 4,9,23 this has yet to be defined in the SFA.
7 Zacharias et al. 343 Potential applications for NIRS-IVUS are similar to IVUS, including accurate assessment of vessel and lumen dimensions, the extent of vessel and lesion calcification, and enhanced characterization of ambiguous lesions. Whether identification of these characteristics will permit more informed selection of endovascular devices (i.e. angioplasty, bare and drug-eluting stents, atherectomy, drug-eluting balloon) is not known at this time. While identification of LCP appears to have value in the coronary arteries for predicting no-reflow, we did not identify flow disturbances in this study. It is possible, but unproven, that LCP in the carotid or renal arteries could have a predictive role for distal embolization; further study is needed. Limitations The primary limitation of this study is the lack of histologic correlation with SFA atherosclerosis by NIRS, since no such studies have been performed. This is in contrast to the coronary circulation, in which NIRS has been validated with histology. Nevertheless, in an appropriately-sized lumen ( 4 mm), there is no reason to expect signals for LCP to be different in PAD patients than in CAD patients. However, other investigators have reported correlations between PAD atherosclerosis and IVUS in the femoral arteries, 26 and IVUS has been reported in PAD patients for identifying plaque rupture. 20 Other studies have compared IVUS and angiography for assessment of vessel and lumen dimensions and for plaque morphology in PAD patients. 19 Two major reviews discussed the applications of IVUS in PAD patients, specifically for assessment of vessel dimensions and plaque morphology. 17,27 Second, the findings in our study are based on 46 lesions at a single center, so larger studies are needed to confirm these findings. Third, our study only evaluated patients with severe PAD who were referred for revascularization for lifestyle-limiting claudication (Rutherford 3) refractory to medical therapy. Therefore, we were unable to evaluate the lipid-core burden in patients with milder disease. Finally, the depth of penetration from the center of the catheter is 3.5 mm for NIRS and 4 mm for IVUS with the 40-MHz transducer, assuming the catheter is in the center of the vessel. Although the SFA RVD was 6.5 mm, the MLD was 2.3 mm, which permitted adequate penetration and consistent images in all lesions. Conclusions NIRS-IVUS demonstrates that nearly all patients with symptomatic severe SFA disease have fibrocalcific plaque, and one-third of such lesions contain LCP. These findings contrast with those in patients with acute coronary syndromes, and may have implications regarding the pathophysiology of atherosclerosis in different vascular beds. Acknowledgements The authors would like to thank Paul A Poronto, RN, BAS for image acquisition and Judith Boura, MS for statistical analysis. Declaration of conflicting interests The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Dr Goldstein is a consultant for, and has equity in, InfraRedX, Inc.; Dr Madder receives research support from InfraRedX, Inc. Funding The authors received no financial support for the research, authorship, and/or publication of this article. References 1. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, Circulation 2004; 110: Stary HC. Natural history and histological classification of atherosclerotic lesions: An update. Arterioscler Thromb Vasc Biol 2000; 20: Waxman S, Dixon SR, L Allier P, et al. In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: Initial results of the SPECTACL study. JACC Cardiovasc Imaging 2009; 2: Goldstein JA, Maini B, Dixon SR, et al. Detection of lipidcore plaques by intracoronary near-infrared spectroscopy identifies high risk of periprocedural myocardial infarction. Circ Cardiovasc Interv 2011; 4: Madder RD, Smith JL, Dixon SR, et al. Composition of target lesions by near-infrared spectroscopy in patients with acute coronary syndrome versus stable angina. Circ Cardiovasc Interv 2012; 5: Gardner CM, Tan H, Hull EL, et al. Detection of lipid core coronary plaques in autopsy specimens with a novel catheterbased near-infrared spectroscopy system. JACC Cardiovasc Imaging 2008; 1: Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001; 37: Li F, McDermott MM, Li D, et al. The association of lesion eccentricity with plaque morphology and components in the superficial femoral artery: A high-spatial-resolution, multicontrast weighted CMR study. J Cardiovasc Magn Reson 2010; 12: Madder RD, Goldstein JA, Madden SP, et al. Detection by near-infrared spectroscopy of large lipid core plaques at culprit sites in patients with acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2013; 6: Dalager S, Paaske WP, Kristensen IB, et al. Artery-related differences in atherosclerosis expression: Implications for atherogenesis and dynamics in intima-media thickness. Stroke 2007; 38: Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: A comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000; 20: Dalager S, Falk E, Kristensen IB, et al. Plaque in superficial femoral arteries indicates generalized atherosclerosis and
8 344 Vascular Medicine 21(4) vulnerability to coronary death: An autopsy study. J Vasc Surg 2008; 47: Sales FJ, Falcão BA, Falcão JL, et al. Evaluation of plaque composition by intravascular ultrasound virtual histology : The impact of dense calcium on the measurement of necrotic tissue. EuroIntervention 2010; 6: Murray SW, Palmer ND. What is behind the calcium? The relationship between calcium and necrotic core on virtual histology analyses. Eur Heart J 2009; 30: 125; author reply Pu J, Mintz GS, Brilakis ES, et al. In vivo characterization of coronary plaques: Novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy. Eur Heart J 2012; 33: Kashyap VS, Pavkov ML, Bishop PD, et al. Angiography underestimates peripheral atherosclerosis: Lumenography revisited. J Endovasc Ther 2008; 15: Lee JT, Fang TD, White RA. Applications of intravascular ultrasound in the treatment of peripheral occlusive disease. Semin Vasc Surg 2006; 19: Otto CM, Pearlman AS. Textbook of Clinical Echocardiography. Philadelphia: WB Saunders, 1995, p.xiv, Arthurs ZM, Bishop PD, Feiten LE, et al. Evaluation of peripheral atherosclerosis: A comparative analysis of angiography and intravascular ultrasound imaging. J Vasc Surg 2010; 51: Okura H, Asawa K, Kubo T, et al. Incidence and predictors of plaque rupture in the peripheral arteries. Circ Cardiovasc Interv 2010; 3: Bishop PD, Feiten LE, Ouriel K, et al. Arterial calcification increases in distal arteries in patients with peripheral arterial disease. Ann Vasc Surg 2008; 22: Pu J, Mintz GS, Biro S, et al. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments. J Am Coll Cardiol 2014; 63: Madder RD, Husaini M, Davis AT, et al. Detection by nearinfrared spectroscopy of large lipid cores at culprit sites in patients with non-st-segment elevation myocardial infarction and unstable angina. Catheter Cardiovasc Interv 2015; 86: Polonsky TS, Liu K, Tian L, et al. High-risk plaque in the superficial femoral artery of people with peripheral artery disease: Prevalence and associated clinical characteristics. Atherosclerosis 2014; 237: Li T, Li X, Zhao X, et al. Classification of human coronary atherosclerotic plaques using ex vivo high-resolution multicontrast-weighted MRI compared with histopathology. AJR Am J Roentgenol 2012; 198: De Korte CL, Pasterkamp G, van der Steen AF, et al. Characterization of plaque components with intravascular ultrasound elastography in human femoral and coronary arteries in vitro. Circulation 2000; 102: Diethrich EB, Irshad K, Reid DB. Virtual histology and color flow intravascular ultrasound in peripheral interventions. Semin Vasc Surg 2006; 19:
Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection
Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection Gary S. Mintz, MD Cardiovascular Research Foundation New York, NY Greyscale IVUS studies have shown Plaque ruptures do not occur randomly
More informationImaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging
Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging Gary S. Mintz,, MD Cardiovascular Research Foundation New York, NY Today, in reality, almost everything
More informationImaging Atheroma The quest for the Vulnerable Plaque
Imaging Atheroma The quest for the Vulnerable Plaque P.J. de Feijter 1. Department of Cardiology 2. Department of Radiology Coronary Heart Disease Remains the Leading Cause of Death in the U.S, Causing
More informationCalcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease
Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease Thomas M. Shimshak, MD Heart and Vascular Center Florida Hospital Heartland Medical Center
More informationCulprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome
Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome Hiroyuki Okura*, MD; Nobuya Matsushita**,MD Kenji Shimeno**, MD; Hiroyuki Yamaghishi**, MD Iku Toda**,
More informationIVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea
IVUS Analysis Myeong-Ki Hong, MD, PhD Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Intimal disease (plaque) is dense and will appear white Media is made of
More informationEvaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013
Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart
More informationCoronary Embolization Following Balloon Dilation of Lipid-Core Plaques
J: RDIOVSULR IMGING VOL. 2, NO. 12, 2009 2009 Y THE MERIN OLLEGE OF RDIOLOGY FOUNDTION ISSN 0735-1097/09/$36.00 PULISHED Y ELSEVIER IN. DOI:10.1016/j.jcmg.2009.10.003 IMGING VIGNETTE oronary Embolization
More informationCardiovascular Research Foundation and Columbia University Medical Center, New York.
Virtual Histology Intravascular Ultrasound Analysis of Non-culprit Attenuated Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes Xiaofan Wu, Akiko Maehara,
More informationOptical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting
Chapter 6 Optical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting Shinichi Yoshimura, Masanori Kawasaki, Kiyofumi Yamada, Arihiro Hattori, Kazuhiko Nishigaki, Shinya Minatoguchi
More informationCLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus
CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus OPTICAL COHERENCE TOMOGRAPHY (OCT) IVUS and OCT IVUS OCT
More informationΚλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE
Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE Conflict of interest None to declare While IVUS is the most used intravascular
More informationIVUS Virtual Histology. Listening through Walls D. Geoffrey Vince, PhD The Cleveland Clinic Foundation
IVUS Virtual Histology Listening through Walls D. Geoffrey Vince, PhD Disclosure VH is licenced to Volcano Therapeutics Grant funding from Pfizer, Inc. Grant funding from Boston-Scientific Most Myocardial
More informationDISRUPT CAD. Todd J. Brinton, MD Clinical Associate Professor of Medicine Adjunct Professor of Bioengineering Stanford University
DISRUPT CAD A multicenter, prospective, single-arm study of percutaneous Lithoplasty prior to stent implantation in heavily calcified coronary lesions Todd J. Brinton, MD Clinical Associate Professor of
More informationGary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function
Gary S. Mintz,, MD IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function Important IVUS Observations: Remodeling Originally used (first by Glagov) ) to explain atherosclerosis
More informationAdded Value of Invasive Coronary Imaging for Plaque Rupture and Erosion
Assessment of Coronary Plaque Rupture and Erosion Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion Yukio Ozaki, MD, PhD, FACC, FESC Cardiology Dept., Fujita Health Univ. Toyoake,
More informationIntracoronary Near-Infrared Spectroscopy (NIRS) Imaging for Detection of Lipid Content of Coronary Plaques: Current Experience and Future Perspectives
Curr Cardiovasc Imaging Rep (2013) 6:426 430 DOI 10.1007/s12410-013-9224-2 INTRAVASCULAR IMAGING (U LANDMESSER, SECTION EDITOR) Intracoronary Near-Infrared Spectroscopy (NIRS) Imaging for Detection of
More informationAssessment of Vulnerable Plaque by IVUS and VH-IVUS
Assessment of Vulnerable Plaque by IVUS and VH-IVUS Akiko Maehara, MD Director of Intravascular Imaging & Physiology Core Laboratories Associate Director of MRI/MDCT Core Laboratory Cardiovascular Research
More informationAtherectomy with thrombectomy of. Rotarex S : The Leipzig experience
Atherectomy with thrombectomy of femoropopliteal occlusions with Rotarex S : The Leipzig experience Dr. Bruno Freitas, Prof., MD Department of Interventional Angiology, Universität Leipzig, Germany Santa
More informationDecrease in lipid rich plaque during percutaneous coronary intervention: reality or artefact? An observational study using Near-Infrared Spectroscopy
Interventional Cardiology Decrease in lipid rich plaque during percutaneous coronary intervention: reality or artefact? An observational study using Background: Lipid rich plaque (LRP) content has been
More informationChapter 43 Noninvasive Coronary Plaque Imaging
hapter 43 Noninvasive oronary Plaque Imaging NIRUDH KOHLI The goal of coronary imaging is to define the extent of luminal narrowing as well as composition of an atherosclerotic plaque to facilitate appropriate
More informationThe Utility of Atherectomy and the Jetstream Atherectomy System
The Utility of Atherectomy and the Jetstream Atherectomy System William A. Gray, MD Columbia University Medical Center 2014 Boston Scientific Corporation or its affiliates. All rights reserved. IMPORTANT
More information1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece
Konstantinos Toutouzas, Maria Riga, Antonios Karanasos, Eleftherios Tsiamis, Andreas Synetos, Maria Drakopoulou, Chrysoula Patsa, Georgia Triantafyllou, Aris Androulakis, Christodoulos Stefanadis 1st Department
More informationUtility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography
Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography Jon C. George, MD; Vincent Varghese, DO From the Deborah Heart and Lung Center, Browns Mills, New Jersey. ABSTRACT:
More informationCoronary Artery Thermography
Coronary Artery Thermography The 10th Anniversary, Interventional Vascular Therapeutics Angioplasty Summit 2005 TCT Asia Pacific Christodoulos Stefanadis Professor of Cardiology Athens Medical School In
More informationAmbiguity in Detection of Necrosis in IVUS Plaque Characterization Algorithms and SDH as Alternative Solution
Ambiguity in Detection of Necrosis in IVUS Plaque Characterization Algorithms and SDH as Alternative Solution Amin Katouzian, Ph.D., Debdoot Sheet, M.S., Abouzar Eslami, Ph.D., Athanasios Karamalis, M.Sc.,
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationClinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD
Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion
More informationIntravascular Ultrasound
May 2008 Beth Israel Deaconess Medical Center Harvard Medical School Intravascular Ultrasound Matthew Altman, HMS III Gillian Lieberman, MD BIDMC Department of Radiology Presentation Overview 1. Patient
More informationAnatomy is Destiny, But Physiology is Here Today
Published on Journal of Invasive Cardiology (http://www.invasivecardiology.com) September, 2010 [1] Anatomy is Destiny, But Physiology is Here Today Thu, 9/9/10-10:54am 0 Comments Section: Commentary Issue
More informationHigh-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens
High-risk vulnerable plaques. Kostis Raisakis G.Gennimatas General Hospital of Athens Overview: 1 Definition-Pathology 2 3 Diagnostic Strategies Invasive Non Invasive Prognostic Value of Detection 4 Treatment
More informationCarotid Intravascular Imaging Technique and Indication
Nurse and Technician Forum Carotid Intravascular Imaging Technique and Indication Gianmarco de Donato Assistant Professor Vascular and Endovascular Surgery University of Siena - Italy Disclosure Speaker
More informationChallenging of contrast agent-free endovascular treatment using 3D imaging
AC17-0010 Challenging of contrast agent-free endovascular treatment using 3D imaging Amane Kozuki Department of Cardiology, Osaka Saiseikai Nakatsu Hospital Introduction With advances in devices and techniques,
More informationTitle for Paragraph Format Slide
Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38
More informationIntervention: How and to which extent is technology helping us?
Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction
More informationThere are multiple endovascular options for treatment
Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA
More informationOCT; Comparative Imaging Results with IVUS, VH and Angioscopy
OCT; Comparative Imaging Results with IVUS, VH and Angioscopy Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Comparison among coronary imaging techniques OCT IVUS MRI CAG Angioscopy
More informationOptical Coherence Tomography
Optical Coherence Tomography Disclosure Information Demetrius Lopes MD The following relationships exist related to this presentation: University Grant/Research Support: Rush University Industry Grant
More informationAssessment of plaque morphology by OCT in patients with ACS
Assessment of plaque morphology by OCT in patients with ACS Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan Unstable plaque Intima Lipid core Plaque rupture and coronary events
More informationEffect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators
More informationDealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?
Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer? Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC 2017 January 25 th 2017 Disclosure
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ABI. See Ankle-brachial index (ABI). Afterload, deconstructing of, in ventricular vascular interaction in heart failure, 449 Air plethysmography
More informationThe PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque
The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively
More informationOptical Coherence Tomography for Intracoronary Imaging
Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland
More informationOrbital Atherectomy Plaque Modification Assessment of the Femoropopliteal Artery Via Intravascular Ultrasound (TRUTH Study)
Article Orbital Atherectomy Plaque Modification Assessment of the Femoropopliteal Artery Via Intravascular Ultrasound (TRUTH Study) Vascular and Endovascular Surgery 2015, Vol. 49(7) 188-194 ª The Author(s)
More informationQuick guide. Core. precision guided therapy system
Quick guide Core precision guided therapy system The Philips Volcano imaging system should only be operated by trained personnel. The following information is presented for your convenience and is not
More informationCan IVUS Define Plaque Features that Impact Patient Care?
Can IVUS Define Plaque Features that Impact Patient Care? A Pichard L Satler, K Kent, R Waksman, W Suddath, N Bernardo, N Weissman, M Angelo, D Harrington, J Lindsay, J Panza. Washington Hospital Center
More informationIntegrated Use of IVUS and FFR for LM Stenting
Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher
More information2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:
Pathology of In-stent Neoatherosclerosis in BMS and DES 197 BMS, 103 SES, and 106 PES with implant duration >30 days The incidence of neoatherosclerosis was significantly greater in DES (31%) than BMS
More informationCT Imaging of Atherosclerotic Plaque. William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA
CT Imaging of Atherosclerotic Plaque William Stanford MD Professor-Emeritus Radiology University of Iowa College of Medicine Iowa City, IA PREVALENCE OF CARDIOVASCULAR DISEASE In 2006 there were 80 million
More informationOriginal Research. differentiated culprit from nonculprit segments with high accuracy (c-statistic=0.83; P<0.001). A threshold maxlcbi 4mm
Original Research Confirmation of the Intracoronary Near-Infrared Spectroscopy Threshold of Lipid-Rich Plaques That Underlie ST-Segment Elevation Myocardial Infarction Ryan D. Madder, Rishi Puri, James
More informationNUCLEAR CARDIOLOGY AND ADVANCED VASCULAR IMAGING. Joel Kahn, MD, FACC
NUCLEAR CARDIOLOGY AND ADVANCED VASCULAR IMAGING Joel Kahn, MD, FACC Short History Nuclear Cardiology Hermann blumgart-1927-injected radon to measure circulation time Hal Anger-1952-gamma camera-beginning
More informationA Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience
A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience Juan F. Granada, MD Medical Director, Skirball Center for Cardiovascular Research The Cardiovascular
More informationRationale and algorithm for below-the-knee acute gain optimization
Leipzig, 01 Feb. 2018 Rationale and algorithm for below-the-knee acute gain optimization Flavio Airoldi, MD Flavio Airoldi Multimedica IRCCS Milan ITALY flavio.airoldi@multimedica.it Rationale Restenosis
More informationPlaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC
Plaque Characteristics in Coronary Artery Disease Chourmouzios Arampatzis MD, PhD, FESC Disclosure Statement of Financial Interest Regarding this Presentation NONE Atherosclerosis Model proposed by Stary
More informationReproducibility of Intravascular Ultrasound imap for Radiofrequency Data Analysis: Implications for Design of Longitudinal Studies
CORONARY ARTERY DISEASE Catheterization and Cardiovascular Interventions 83:E233 E242 (2014) Original Studies Reproducibility of Intravascular Ultrasound imap for Radiofrequency Data Analysis: Implications
More informationTurbo-Power. Laser atherectomy catheter. The standard. for ISR
Turbo-Power Laser atherectomy catheter The standard for ISR Vaporize the ISR challenge In-stent restenosis (ISR) Chance of recurring 7 115,000 + /year (U.S.) 1-6 Repeated narrowing of the arteries after
More informationAtherectomy: Jetstream and Directional. George S. Chrysant, M.D.
Atherectomy: Jetstream and Directional George S. Chrysant, M.D. Disclosures Abbott Vascular: MAB, consultant, proctor Abiomed: consultant Boston Scientific: MAB, consultant, proctor Medicines Company:
More informationComplex PCI. Your partner in complex PCI: In-stent restenosis (ISR)
Comple PCI Your partner in comple PCI: Your partner in comple PCI: Philips provides a portfolio of specialty coronary diagnostic and therapy devices that enable safe and effective treatment of a wide variety
More informationOCT. molecular imaging J Jpn Coll Angiol, 2008, 48: molecular imaging MRI positron-emission tomography PET IMT
48 6 CT MRI PET OCT molecular imaging J Jpn Coll Angiol, 2008, 48: 456 461 atherosclerosis, imaging gold standard computed tomography CT magnetic resonance imaging MRI CT B intima media thickness IMT B
More informationFFR and intravascular imaging, which of which?
FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment
More informationCopyright HMP Communications
Ocelot With Wildcat in a Complicated Superficial Femoral Artery Chronic Total Occlusion Soundos K. Moualla, MD, FACC, FSCAI; Richard R. Heuser, MD, FACC, FACP, FESC, FSCAI From Phoenix Heart Center, Phoenix,
More informationOptimal assessment observation of intravascular ultrasound
Optimal assessment observation of intravascular ultrasound Katsutoshi Kawamura and Atsunori Okamura Division of Radiology Cardiovascular Center Sakurabashi Watanabe Hospital SAKURABASHI WATANABE Hospital
More informationCopyright HMP Communications. Intravascular Ultrasound is Critical to Insuring Long-Term Stent Performance. Normal Vessel. Intima. Media.
CLINICAL REVIEW: IVUS IN PAD Intravascular Ultrasound is Critical to Insuring Long-Term Stent Performance Clifford J. Buckley, MD, FACS Introduction In 1972, Bom and colleagues described the application
More informationWho Cares About the Past?
Risk Factors, the New Calcium Score, Rheology and Atherosclerosis Progression Arthur Agatston 2/21/15 The Vulnerable Plaque vs. Plaque Burden CT Angiogram Is There a Role for Coronary Artery Calcium Scoring
More informationCottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?
Cottrell Memorial Lecture Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease? Stephen Nicholls MBBS PhD @SAHMRI_Heart Disclosures Research support: AstraZeneca,
More informationOCT Findings: Lesson from Stable vs Unstable Plaques
ANGIOPLASTY SUMMIT TCTAP 2010 Imaging Workshop OCT Findings: Lesson from Stable vs Unstable Plaques Giulio Guagliumi MD Ospedali Riuniti di Bergamo, Italy DISCLOSURE OF FINANCIAL INTERESTS Consultant Boston
More informationDESolve NX Trial Clinical and Imaging Results
DESolve NX Trial Clinical and Imaging Results Alexandre Abizaid, MD, PhD, Instituto Dante Pazzanese, Sao Paulo, Brazil On behalf of the DESolve Nx Trial Investigators Please refer to the TCT2014 App or
More informationPost PCI functional testing and imaging: case based lessons from FFR React
Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest
More informationCardiac CT Angiography
Cardiac CT Angiography Dr James Chafey, Radiologist Why do we need a better test for C.A.D? 1. CAD is the leading cause of death in the US CAD 31% Cancer 23% Stroke 7% 2. The prevalence of atherosclerosis
More informationShockwave Intravascular Lithotripsy System treatment of calcified lesions: Intravascular OCT analysis
Shockwave Intravascular Lithotripsy System treatment of calcified lesions: Intravascular OCT analysis Andrew Holden, MBChB, FRANZCR, EBIR Director of Interventional Radiology Auckland, New Zealand LINC
More informationDefining Plaque Composition by CTA: The Latest Tool to Monitor Therapy?
Defining Plaque Composition by CTA: The Latest Tool to Monitor Therapy? John McB. Hodgson, M.D., FSCAI Chairman, Department of Cardiology Geisinger Health System Wilkes Barre,, Pa Disclosure Information
More informationMedical sciences 1 (2017) 1 9
Medical sciences 1 (2017) 1 9 TISSUE CHARACTERISTICS OF CULPRIT CORONARY LESIONS IN ACUTE CORONARY SYNDROME AND TARGET CORONARY LESIONS IN STABLE ANGINA PECTORIS: VIRTUAL HISTOLOGY AND INTRAVASCULAR ULTRASOUND
More informationMachine Learning in Precision Medicine Coronary Health Prediction - Cardiac Events (Atherosclerosis) - Heart Transplant (Vasculopathy)
Machine Learning in Precision Medicine Coronary Health Prediction - Cardiac Events (Atherosclerosis) - Heart Transplant (Vasculopathy) M. Sonka + IIBI, Charles University, IKEM, CKTCH The University of
More informationNew Insight about FFR and IVUS MLA
New Insight about FFR and IVUS MLA Can IVUS MLA Predict FFR
More informationAnalysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent
Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent implantation. Department of Cardiology, Ehime Prefectural Imabari
More informationThe present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio
The present status of selfexpanding and balloonexpandable tibial BMS and DES for CLI: Why and when to use Sean P Lyden MD Cleveland Clinic Cleveland, Ohio Disclosure Speaker name: Sean Lyden, MD I have
More informationThe Role of Lithotripsy in Solving the Challenges of Vascular Calcium. Thomas Zeller, MD
The Role of Lithotripsy in Solving the Challenges of Vascular Calcium Thomas Zeller, MD 1 1 Disclosure Speaker name: Thomas Zeller... I have the following potential conflicts of interest to report: X X
More informationState of the Art. Advances in Cardiovascular Imaging. ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC
State of the Art Advances in Cardiovascular Imaging ESC Congres Stockholm September 1, 2010 Frank E. Rademakers, MD, PhD, FESC Coronary Artery Disease Content Patho Physiology Imaging requirements Economical
More informationOCT guided procedures in peripheral intervention
OCT guided procedures in peripheral intervention Ulrich Sunderdiek, M.D., PhD. Interventional Radiology Marienhospital Osnabrueck, Germany ulrich.sunderdiek@mho.de Recanalisation Popliteal Artery AFS li.
More informationINSIDE INFORMATION YOU CAN T IGNORE
INSIDE INFORMATION YOU CAN T IGNORE Volcano, the Volcano logo and SyncVision are registered trademarks of Volcano Corporation. All other trademarks set-forth are properties of their respective owners.
More informationNoninvasive Coronary Imaging: Plaque Imaging by MDCT
Coronary Physiology & Imaging Summit 2007 Noninvasive Coronary Imaging: Plaque Imaging by MDCT Byoung Wook Choi Department of Radiology Yonsei University, Seoul, Korea Stary, H. C. et al. Circulation
More informationVulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark
Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem
More informationIntroduction What Causes Peripheral Vascular Disease? How Do Doctors Treat Peripheral Vascular Disease?... 9
Patient Information Table of Contents Introduction... 3 What is Peripheral Vascular Disease?... 5 What Are Some of the Symptoms of Peripheral Vascular Disease?... 7 What Causes Peripheral Vascular Disease?...
More informationAccurate Vessel Sizing Drives Clinical Results. IVUS In the Periphery
Accurate Vessel Sizing Drives Clinical Results IVUS In the Periphery Discussion Iida O, et. al. Study Efficacy of Intravascular Ultrasound in Femoropopliteal Stenting for Peripheral Artery Disease With
More informationPlaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD
Plaque Imaging: What It Can Tell Us Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD Buffalo Disclosure Information FINANCIAL DISCLOSURE: Research and consultant
More informationFailure of positive. Recanalization and CTO formation. TCFA rupture with (fatal) thrombotic occlusion. TCFA Lipid pool
Vulnerable Plaque features on coronary CT Jin Ho Choi, MD, PhD Department of Internal Medicine, Emergency Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea IPS /
More informationIntroduction 3. What is Peripheral Vascular Disease? 5. What Are Some of the Symptoms of Peripheral Vascular Disease? 6
Patient Information Table of Contents Introduction 3 What is Peripheral Vascular Disease? 5 What Are Some of the Symptoms of Peripheral Vascular Disease? 6 What Causes Peripheral Vascular Disease? 7 How
More informationLeft main coronary artery (LMCA): The proximal segment
Anatomy and Pathology of Left main coronary artery G Nakazawa Tokai Univ. Kanagawa, Japan 1 Anatomy Difinition Left main coronary artery (LMCA): The proximal segment RCA AV LAD LM LCX of the left coronary
More informationJoshua A. Beckman, MD. Brigham and Women s Hospital
Peripheral Vascular Disease: Overview, Peripheral Arterial Obstructive Disease, Carotid Artery Disease, and Renovascular Disease as a Surrogate for Coronary Artery Disease Joshua A. Beckman, MD Brigham
More informationCover Page. Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence tomography Issue Date:
Cover Page The handle http://hdl.handle.net/1887/29690 holds various files of this Leiden University dissertation Author: Wang, Ancong Title: Automatic quantification of intravascular optical coherence
More informationSites of Atherosclerosis In order of Frequency
Pathological Features of Peripheral Atherosclerosis: Implication for Device Development G Nakazawa Tokai Univ. Kanagawa, Japan 1 Sites of Atherosclerosis In order of Frequency carotid (3) (3) Coronary
More informationBifurcation stenting with BVS
Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have
More informationChapter 11. Departments of 1 Cardiology and 2 Radiology, Leiden University Medical Center, Leiden, The Netherlands. Department of Cardiology,
Chapter 11 Type 2 Diabetes is Associated With More Advanced Coronary Atherosclerosis on Multislice Computed Tomography and Virtual Histology Intravascular Ultrasound Gabija Pundziute, 1,3 Joanne D. Schuijf,
More informationTOBA II 12-Month Results Tack Optimized Balloon Angioplasty
TOBA II 12-Month Results Tack Optimized Balloon Angioplasty William Gray, MD System Chief, Cardiovascular Division Main Line Health, Philadelphia, PA Dissection: The Primary Mechanism of Angioplasty Lesions
More informationPeripheral artery disease (PAD) is a major cause of
Effective Debulking With the JETSTREAM System Strategies for effective treatment of PAD in the era of drug-coated balloons and contemporary stenting. BY THOMAS M. SHIMSHAK, MD, FACC, FSCAI Variable TABLE
More informationNon Invasive Diagnostic Modalities for Coronary Artery Disease. Dr. Amitesh Aggarwal
Non Invasive Diagnostic Modalities for Coronary Artery Disease Dr. Amitesh Aggarwal Ebers papyrus, ca. 1555 BCE If thou examine a man for illness in his cardia, and he has pains in his arms, in his breasts
More informationCurrent Role of Renal Artery Stenting in Patients with Renal Artery Stenosis
Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular
More informationThe Struggle to Manage Stroke, Aneurysm and PAD
The Struggle to Manage Stroke, Aneurysm and PAD In this article, Dr. Salvian examines the management of peripheral arterial disease, aortic aneurysmal disease and cerebrovascular disease from symptomatology
More informationPCI for Chronic Total Occlusions
PCI for Chronic Total Occlusions Chronic Total Occlusions Why not Medical Treatment? Medical Treatment CTO in 891 pts over 24 years High 10% Mortality Low 2 % 1 year 10 years Puma JA, et al. JACC 1994;23:390A
More information